Advertisement

Elanco Animal Health Incorporated ELAN

Set alert

Price alert · ELAN

All alert types
23.06 USD -0.18 -0.77%

At close · Oct 30

23.05 -0.01 -0.03%

After hours · Oct 30, 5:05 PM ET

Bid
23.05 × 500
Ask
23.06 × 700
22.93 Day range 23.48
19.80 52-week range 26.84
YTD
+1.90%
1 year
+2.17%
Open
23.48
Prev close
23.24
Mkt cap
11.52B
Vol
3.45M
Avg vol
6.18M
EPS
-0.41
P/E
0.00
Div yield
0.00%
More statistics
Low
22.93
High
23.48
Forward P/E
18.12
Beta
1.71
Short ratio
5.57
Inst. own
115.51%
Dividend
0.00
Ex-div date
Earnings
Nov 6, 2026
50-d avg
23.13
200-d avg
23.80
1y target
30.23

MAX chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: 0.26; estimate 0.2; surprise 30%
  • Nov 5, 2025Earnings: 0.19; estimate 0.13; surprise 46.15%
  • Feb 24, 2026Earnings: 0.13; estimate 0.11; surprise 18.18%
  • May 6, 2026Earnings: 0.4; estimate 0.3456; surprise 15.74%
  • Jul 22, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • Aug 5, 2026Earnings: 0.34; estimate 0.2692; surprise 26.3%
  • Aug 6, 2026Rating: Keybanc · Overweight → Overweight
  • Aug 6, 2026Rating: UBS · Buy → Buy
  • Oct 16, 2026Rating: Goldman Sachs · — → Buy
  • Oct 20, 2026Downgrade: Jefferies · Buy → Hold
  • Oct 29, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
Signals (162)
NameDateAgo
SMA: BullishOct 29, 20262 days ago
SMA: BearishOct 19, 20261 week ago
SMA: BearishOct 19, 20261 week ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 3, 20263 months ago
SMA: BearishAug 3, 20263 months ago
MACD: Sell SignalAug 3, 20263 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BearishMar 2, 20268 months ago
MACD: Sell SignalMar 2, 20268 months ago
MACD: Buy SignalFeb 23, 20268 months ago
MACD: Sell SignalFeb 16, 20268 months ago
MACD: Buy SignalFeb 2, 20269 months ago
RSI: OverboughtFeb 2, 20269 months ago
RSI: OverboughtJan 12, 20269 months ago
SMA: BullishDec 15, 202510 months ago
SMA: BearishDec 8, 202510 months ago
MACD: Sell SignalDec 8, 202510 months ago
RSI: OverboughtNov 17, 202511 months ago
RSI: OverboughtAug 11, 20251 year ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishMay 5, 20251 year ago
SMA: BullishMay 5, 20251 year ago
MACD: Buy SignalMay 5, 20251 year ago
RSI: OversoldMar 31, 20251 year ago
SMA: BearishNov 18, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BearishOct 7, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BullishAug 26, 20242 years ago
SMA: BullishAug 12, 20242 years ago
SMA: BearishJun 24, 20242 years ago
SMA: BearishJun 24, 20242 years ago
MACD: Sell SignalJun 24, 20242 years ago
MACD: Buy SignalMay 20, 20242 years ago
SMA: BullishMay 6, 20242 years ago
SMA: BullishMay 6, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BearishApr 1, 20242 years ago
MACD: Sell SignalApr 1, 20242 years ago
RSI: OverboughtFeb 19, 20242 years ago
RSI: OverboughtDec 25, 20232 years ago
MACD: Buy SignalNov 13, 20232 years ago
SMA: BullishNov 6, 20232 years ago
SMA: BullishNov 6, 20232 years ago
SMA: BearishOct 2, 20233 years ago
MACD: Sell SignalOct 2, 20233 years ago
SMA: BearishSep 18, 20233 years ago
SMA: BullishSep 11, 20233 years ago
SMA: BearishSep 4, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BullishJun 12, 20233 years ago
SMA: BearishJun 5, 20233 years ago
SMA: BullishMay 29, 20233 years ago
RSI: OversoldMay 22, 20233 years ago
MACD: Buy SignalApr 17, 20233 years ago
RSI: OversoldApr 3, 20233 years ago
MACD: Sell SignalMar 13, 20233 years ago
RSI: OversoldMar 6, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishJan 2, 20233 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishNov 28, 20223 years ago
SMA: BearishNov 14, 20223 years ago
RSI: OversoldNov 14, 20223 years ago
SMA: BullishNov 7, 20223 years ago
MACD: Buy SignalNov 7, 20223 years ago
RSI: OversoldAug 15, 20224 years ago
RSI: OversoldAug 1, 20224 years ago
RSI: OversoldJun 13, 20224 years ago
RSI: OversoldMay 9, 20224 years ago
MACD: Sell SignalMay 2, 20224 years ago
SMA: BearishMar 28, 20224 years ago
MACD: Buy SignalFeb 28, 20224 years ago
SMA: BullishFeb 21, 20224 years ago
RSI: OversoldJan 31, 20224 years ago
SMA: BearishNov 15, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishOct 25, 20215 years ago
SMA: BearishOct 25, 20215 years ago
SMA: BullishOct 18, 20215 years ago
SMA: BullishOct 18, 20215 years ago
SMA: BearishOct 11, 20215 years ago
SMA: BearishOct 11, 20215 years ago
SMA: BullishOct 4, 20215 years ago
SMA: BullishOct 4, 20215 years ago
SMA: BearishSep 13, 20215 years ago
SMA: BullishAug 23, 20215 years ago
SMA: BearishAug 9, 20215 years ago
SMA: BearishAug 9, 20215 years ago
MACD: Sell SignalAug 9, 20215 years ago
SMA: BullishJul 19, 20215 years ago
SMA: BearishJul 5, 20215 years ago
MACD: Buy SignalMay 3, 20215 years ago
SMA: BullishApr 19, 20215 years ago
SMA: BullishApr 19, 20215 years ago
SMA: BearishMar 22, 20215 years ago
SMA: BearishMar 22, 20215 years ago
MACD: Sell SignalMar 22, 20215 years ago
MACD: Buy SignalMar 8, 20215 years ago
SMA: BullishFeb 22, 20215 years ago
SMA: BullishFeb 8, 20215 years ago
SMA: BearishFeb 1, 20215 years ago
SMA: BearishJan 25, 20215 years ago
SMA: BullishDec 21, 20205 years ago
MACD: Sell SignalDec 7, 20205 years ago
SMA: BearishNov 30, 20205 years ago
SMA: BullishNov 23, 20205 years ago
SMA: BearishNov 16, 20205 years ago
SMA: BullishAug 3, 20206 years ago
SMA: BullishJul 6, 20206 years ago
SMA: BearishJun 22, 20206 years ago
SMA: BullishJun 15, 20206 years ago
SMA: BearishJun 8, 20206 years ago
MACD: Buy SignalJun 8, 20206 years ago
SMA: BullishJun 1, 20206 years ago
SMA: BearishMay 4, 20206 years ago
RSI: OversoldMar 9, 20206 years ago
MACD: Sell SignalMar 2, 20206 years ago
SMA: BearishFeb 24, 20206 years ago
SMA: BearishFeb 24, 20206 years ago
SMA: BullishJan 13, 20206 years ago
SMA: BearishJan 6, 20206 years ago
SMA: BullishDec 23, 20196 years ago
SMA: BullishNov 25, 20196 years ago
MACD: Buy SignalNov 25, 20196 years ago
SMA: BearishNov 11, 20196 years ago
SMA: BullishOct 28, 20197 years ago
SMA: BearishAug 5, 20197 years ago
MACD: Sell SignalAug 5, 20197 years ago
SMA: BearishJul 29, 20197 years ago
SMA: BullishJul 22, 20197 years ago
SMA: BearishJul 15, 20197 years ago
SMA: BullishJun 17, 20197 years ago
SMA: BearishJun 10, 20197 years ago
SMA: BullishJun 3, 20197 years ago
SMA: BullishJun 3, 20197 years ago
SMA: BearishMay 27, 20197 years ago
SMA: BearishMay 20, 20197 years ago
SMA: BullishApr 22, 20197 years ago
SMA: BullishApr 22, 20197 years ago
SMA: BearishApr 15, 20197 years ago
SMA: BearishApr 15, 20197 years ago
SMA: BullishMar 11, 20197 years ago
SMA: BearishMar 4, 20197 years ago
SMA: BullishFeb 25, 20197 years ago
SMA: BearishDec 10, 20187 years ago
SMA: BullishDec 3, 20187 years ago
SMA: BearishNov 26, 20187 years ago

Key statistics

Market cap
11.52B
Enterprise value
15.31B
Trailing P/E
0.00
Forward P/E
18.12
PEG ratio
4.04
Price / sales
2.30
Price / book
1.75
EPS (TTM)
-0.41
Beta
1.71
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-3.96%
Revenue (TTM)
5.02B
Revenue growth
10.20%
Free cash flow
826.88M
Total cash
530.00M
Total debt
4.23B
Return on equity
-2.98%
Shares outstanding
499.62M
Short % of float
9.89%
50-day average
23.13
200-day average
23.80

Analyst view

Consensus: buy

Buy
Price target (mean) 30.23 +31.1% upside
Target (low)
24.00
Target (mean)
30.23
Target (high)
34.00
Ratings (0m) 16 13 buy · 3 hold · 0 sell
  • Strong buy4
  • Buy9
  • Hold3
  • Sell0
  • Strong sell0

Next earnings

Nov 6, 2026

Expected Nov 6, 2026. Consensus EPS estimate 0.20328.

Earnings history

Financials — quick view

All financials
ELAN Revenue — quarterly 1.37B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ELAN Net income — quarterly 54.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ELAN EPS — quarterly 0.11
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ELAN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2026Sep 30, 20260.2028———
Aug 5, 2026Jun 30, 20260.26920.34+0.07+26.30%
May 6, 2026Mar 31, 20260.34560.40+0.05+15.74%
Feb 24, 2026Dec 31, 20250.110.13+0.02+18.18%
Nov 5, 2025Sep 30, 20250.130.19+0.06+46.15%
Aug 7, 2025Jun 30, 20250.200.26+0.06+30.00%

Upgrades / downgrades

ELAN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 29, 2026Morgan StanleymainEqual-WeightEqual-Weight
Oct 20, 2026JefferiesdownBuyHold
Oct 16, 2026Goldman Sachsinit—Buy
Aug 6, 2026UBSmainBuyBuy
Aug 6, 2026KeybancmainOverweightOverweight
Jul 22, 2026Morgan StanleymainEqual-WeightEqual-Weight

About Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
elanco.com

News

Your note

Sign in to keep a note on ELAN — it syncs with the Stock Master app.

Insider holders

ELAN insider holders
InsiderRelationLatest transactionDateShares held
BETTINGTON TIMOTHY JOfficerSaleOct 14, 2026138,911
CABRAL RAMIRO MARTINOfficerStock Award(Grant)Feb 26, 2026290,366
DE BRABANDER ELLENOfficerStock Award(Grant)Mar 31, 2026280,821
HOOVER R DAVIDDirectorStock Award(Grant)May 20, 2026277,371
KINARD DAVID SOfficerStock Award(Grant)Feb 26, 2026217,697
KURZIUS LAWRENCE ERIKDirectorPurchaseAug 19, 2026188,647

Institution ownership

ELAN institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.13.49%67,397,0251.55BJun 29, 2026
FMR, LLC11.40%56,948,8191.31BJun 29, 2026
Blackrock Inc.9.78%48,849,9731.13BJun 29, 2026
Primecap Management Company9.10%45,445,0121.05BJun 29, 2026
T. Rowe Price Investment Management, Inc.5.75%28,750,719662.99MJun 29, 2026
Dimensional Fund Advisors LP5.09%25,417,271586.12MJun 29, 2026

Fund ownership

ELAN fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.63%43,107,500994.06MJun 29, 2026
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%17,796,673410.39MSep 29, 2026
VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund3.55%17,751,139409.34MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%15,872,148366.01MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%11,448,318264.00MJun 29, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 2.07%10,339,390238.43MAug 30, 2026
Advertisement